M&A Transactions

Quince Therapeutics, Inc. completed an acquisition involving EryDel S.p.A for 6,525,315 shares of common stock (closed 2023-10-20).

“company solely in its capacity as the representative, agent and attorney-in-fact of the EryDel Shareholders. Pursuant to the terms of the Purchase Agreement, the Company issued 6,525,315 shares of common stock of the Company to the EryDel Shareholders, resulting in the EryDel Shareholders owning approximately 15.2% of the outstanding common stock of the Company.”

PFSWEB INC underwent a change of control involving GXO Logistics, Inc. for $7.50 per Share in cash (closed 2023-10-23).

“the “Shares”) (other than Shares held by Parent, Merger Sub, the Company or any of their respective subsidiaries as treasury stock or otherwise) at a price per Share of $7.50, in cash, without interest and less any applicable withholding taxes (the “Offer Price”). The Offer expired at the end of the day, 12:00 midnight, New York City time, on October”

NCR Voyix Corp completed a disposition involving NCR Atleos Corporation (closed 2023-10-16).

“Voyix completed the pro rata distribution to holders of record of Voyix’s common stock, par value $0.01 per share (“Voyix Common Stock”), as of 5:00 p.m. local New York City time on October 2, 2023 (the “Record Date”), of one share of NCR Atleos Corporation (“Atleos”) common stock, par value $0.01 per share (“Atleos Common Stock”), for every two shares of Voyix Common Stock held by such Voyix common stockholders as of the Record Date (the “Distribution”).”

Tourmaline Bio, Inc. completed an acquisition involving Tourmaline Bio, Inc. (as target) (closed 2023-10-19).

“On October 19, 2023, the Company, Merger Sub and Tourmaline consummated the transactions contemplated by the Merger Agreement”

Tourmaline Bio, Inc. underwent a change of control involving Tourmaline Bio, Inc. (formerly Tourmaline Sub, Inc.) for exchange ratio of 0.7977 shares of the Company’s common stock for each share of Tourmaline common stock (closed 2023-10-19).

“effective time of the Merger, the Company issued an aggregate of approximately 15,877,090 shares of its common stock to Tourmaline’s stockholders, based on an exchange ratio of 0.7977 (without giving effect to the Reverse Stock Split) shares of the Company’s common stock for each share of Tourmaline common stock outstanding immediately prior to the Merger,”

Ayala Pharmaceuticals, Inc. completed an acquisition involving Biosight Ltd. (closed 2023-10-18).

“On October 18, 2023 (the “Closing Date”), pursuant to the Merger Agreement, Merger Sub consummated the merger with and into Biosight, with Biosight continuing as the surviving company and a wholly-owned subsidiary of the Registrant (the “Merger”).”

Champion Homes, Inc. completed an acquisition involving Regional Holdings Corporation, Regional Underwriters, Inc., Heath Jenkins, Dana Jenkins for approximately $313,000,000, net of cash acquired, plus assumed debt, primarily related to inventory floor plan liabilities, of $93,000,000 (closed 2023-10-13).

“being a “Regional Home Company”) from the Sellers and Dana Jenkins (collectively, the “Transaction”). On the Closing Date, Skyline, through Buyers, paid to Sellers approximately $313,000,000, net of cash acquired, plus assumed debt, primarily related to inventory floor plan liabilities, of $93,000,000. In addition, the Company issued 379,248 shares of common stock in”

Athena Consumer Acquisition Corp. underwent a change of control involving Next.e.GO Mobile SE for 79,019,608 newly issued TopCo ordinary shares (closed 2023-10-19).

“y and among Athena, Next.e.GO Mobile SE, a European company incorporated in Germany (“ e.GO ”), Next.e.GO B.V.,”

La Rosa Holdings Corp. completed an acquisition involving Horeb Kissimmee Realty, LLC for $500,000 in cash and issued the Selling Member an aggregate of 513,626 unregistered shares of the Company’s common stock (closed 2023-10-16).

“interest in Kissimmee (the “Selling Member”). As the consideration for the Company acquisition of the Majority Interests of Kissimmee Realty, the Company paid the Selling Member $500,000 in cash and issued the Selling Member an aggregate of 513,626 unregistered shares of the Company’s common stock (the “Kissimmee Purchase Shares”). On October 16, 2023, the Selling”

La Rosa Holdings Corp. completed an acquisition involving La Rosa Realty Lake Nona, Inc. for $50,000 in cash and issued the Selling Stockholder an aggregate of 324,998 unregistered shares of the Company’s common stock (closed 2023-10-13).

“the Company, Lake Nona and the sole stockholder of Lake Nona (the “Selling Stockholder”). As the consideration for the Majority Shares, the Company paid the Selling Stockholder $50,000 in cash and issued the Selling Stockholder an aggregate of 324,998 unregistered shares of the Company’s common stock (the “Lake Nona Purchase Shares”). The Selling Stockholder”

CIRCOR INTERNATIONAL INC underwent a change of control involving Kohlberg Kravis Roberts & Co. L.P. (KKR) (through affiliates Cube BidCo, Inc. and Cube Merger Sub, Inc.) for $56.00 per share in cash (closed 2023-10-18).

“in the Merger Agreement) (collectively, “ Excluded Shares ”) immediately prior to the Effective Time), was converted into the right to receive an amount in cash equal to $56.00, without interest (the “ Per Share Consideration ”), less any applicable withholding taxes; • each option to purchase shares of Company Common Stock (a “ Company Stock Option ”)”

EMAGIN CORP underwent a change of control involving Samsung Display Co., Ltd. for $2.08 per share in an all-cash transaction valued at approximately $218 million (closed 2023-10-18).

“of its acquisition by Samsung Display Co., Ltd. (“Samsung Display”), a subsidiary of Samsung Electronics Co., Ltd. and manufacturer and distributor of display products, for $2.08 per share in an all-cash transaction valued at approximately $218 million. “I know I speak for everyone at eMagin when I say that we are very excited to be teaming with Samsung”

NCR Voyix Corp completed a disposition involving NCR Atleos Corporation (closed 2023-10-16).

“Voyix completed the Spin-Off through a pro rata distribution to holders of record of Voyix’s common stock, par value $0.01 per share (“Voyix Common Stock”), as of 5:00 p.m. local New York City time on October 2, 2023 (the “Record Date”), of one share of Atleos’ common stock, par value $0.01 per share (“Atleos Common Stock”), for every two shares of Voyix Common Stock held by such Voyix common stockholders as of the Record Date (the “Distribution”).”

SunOpta Inc. completed a disposition involving Natures Touch Mexico, S. de R.L. de C.V. and Nature's Touch Frozen Fruits, LLC for $141 million (closed 2023-10-12).

“packaging and selling individually quick frozen fruit for retail, foodservice and industrial applications in Edwardsville, Kansas and Jacona, Michoacan, Mexico, valued at $141 million, inclusive of $20 million of seller promissory notes due in three years (the " Transaction "). On October 12, 2023, the Company completed the Transaction in accordance with the”

Metaterra Corp. underwent a change of control involving Miracle Technologies Holding SGPS, LDA (closed 2023-10-13).

“On October 13, 2023, Anyoline De Jesus De Perez, the previous majority shareholder of the Company, entered into a stock purchase agreement for the sale of 2,000,000 shares of Common Stock of the Company, to Miracle Technologies Holding SGPS, LDA, located at Rua dos Murças, n.° 15, 3.° andar, Fração L, Distrito da Ilha da Madeira, 9000 058 Funchal, Portugal.”

Thorne Healthtech, Inc. underwent a change of control involving Healthspan Buyer, LLC and Healthspan Merger Sub, Inc. (affiliates of L Catterton) for $10.20 per Share (closed 2023-10-16).

“on September 14, 2023 (the “Offer”) to purchase all of the issued and outstanding shares of Thorne’s common stock, par value $0.01 per share (the “Shares”) at an offer price of $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes and any Dividend Adjustments (as defined in the Offer to Purchase) (the “Per Share”

Notable Labs, Ltd. completed a disposition involving Immunewalk Therapeutics Inc. for an upfront cash payment of $250,000 to the Company at the closing and additional payments of up to $4.75 million upon the achievement of clinical and commercial (closed 2023-10-16).

“of October 1, 2023, between the Company and Immunewalk (the “Asset Purchase Agreement”). Under the Asset Purchase Agreement, Immunewalk agreed to pay an upfront cash payment of $250,000 to the Company at the closing and additional payments of up to $4.75 million upon the achievement of clinical and commercial milestones by Immunewalk, its Affiliates or Licensees.”

Notable Labs, Ltd. underwent a change of control involving Notable Labs, Inc. (closed 2023-10-16).

“On October 16, 2023, Notable Labs, Ltd., formerly known as "Vascular Biogenics Ltd." (the "Company" or "VBL"), completed its business combination with Notable Labs, Inc. ("Notable") and Vibrant Merger Sub, Inc., a wholly-owned subsidiary of the Company ("Merger Sub") in accordance with the terms of the Agreement and Plan of Merger, dated as of February 22, 2023 (the "Merger Agreement"), by and among the Company, Notable and Merger Sub.”

MICROSOFT CORP completed an acquisition involving Activision Blizzard, Inc. for $95.00 per share in cash (closed 2023-10-13).

“On October 13, 2023, Microsoft Corporation, a Washington corporation (“Microsoft”), completed its previously announced acquisition of Activision Blizzard, Inc., a Delaware corporation (“Activision Blizzard”). Pursuant to the terms of the Agreement and Plan of Merger (as amended, supplemented or otherwise modified from time to time, the “Merger Agreement”), dated as of January 18, 2022, by and among Microsoft, Activision Blizzard and Anchorage Merger Sub Inc., a Delaware corporation and a wholly owned subsidiary of Microsoft (“Merger Sub”), at the effective time of the Merger (the “Effective Time”), Merger Sub merged with and into Activision Blizzard (the “Merger”), with Activision Blizzard surviving the Merger as a wholly owned subsidiary of Microsoft.”

Activision Blizzard, Inc. underwent a change of control involving Microsoft Corporation for $95.00 in cash (closed 2023-10-13).

“nnounced transaction with Microsoft Corporation, a Washington corporation (“ Parent ”), pursuant to the Agreement and”

SunPower Inc. completed a disposition involving Maxeon Solar Technologies, Ltd. for 1,100,000 Maxeon ordinary shares (closed 2023-10-06).

“to the Agreement, the parties consummated the sale, thereby completing the disposition of the Purchased Assets. As consideration for the Purchased Assets, the Company received 1,100,000 Maxeon ordinary shares. The unaudited pro forma combined financial information of the Company as of and for the six months ended June 30, 2023 and for the year ended December 31,”

FITLIFE BRANDS, INC. completed an acquisition involving MusclePharm Corporation for $18.5 million (closed 2023-10-10).

“(the “ Purchase Agreement ”), pursuant to which a subsidiary of the Company agreed to acquire substantially all of MusclePharm’s assets (the “ Assets ”), for a purchase price of $18.5 million, subject to certain adjustments (the “ Purchase Price ”)(the “ Acquisition ”). The Acquisition was consummated on October 10, 2023 (the “ Closing Date ”) in accordance with the”

EMCORE CORP completed a disposition involving Photonics Foundries, Inc. (PF) and Ortel LLC (the Buyer).

“Item 2.01 Completion of Acquisition or Disposition of Assets. The disclosures regarding the Purchase Agreement and the Transaction set forth in Item 1.01 above is incorporated by reference into this Item 2.01.”

Falcon's Beyond Global, Inc. completed an acquisition involving Falcon’s Beyond Global, LLC (closed 2023-10-06).

“on October 6, 2023 (the “Acquisition Merger Effective Time”), Merger Sub merged with and into the Company (the “Acquisition Merger,” and collectively with the SPAC Merger, the “Business Combination”), with the Company as the surviving entity of such merger”

Falcon's Beyond Global, Inc. underwent a change of control involving FAST Acquisition Corp. II (closed 2023-10-05).

“on October 5, 2023 (the “SPAC Merger Effective Time”), FAST II merged with and into Pubco (the “SPAC Merger”), with Pubco surviving as the sole owner of Merger Sub”

Ocean Biomedical, Inc. completed an acquisition involving Virion Therapeutics, LLC for $4,100,000 or a total of 750,000 shares of Company common stock (closed 2023-10-11).

“Agreement in its entirety. As consideration for its interest in Virion, Ocean Biomedical agreed to contribute to Virion, at its discretion, either cash in an amount equal to $4,100,000 or a total of 750,000 shares of Company common stock, with 250,000 of those shares to be delivered to Virion by Poseidon within five business days of closing, and the remainder to”

NATIONAL INSTRUMENTS CORP underwent a change of control involving Emerson Electric Co. for $60.00 in cash (closed 2023-10-11).

“appraisal of such shares pursuant to Section 262 of the General Corporation Law of the State of Delaware (the “DGCL”)) was automatically converted into the right to receive $60.00 in cash (the “Merger Consideration”). Additionally, at the Effective Time, each share of common stock, par value $1.00 per share, of Merger Sub outstanding immediately prior to”

iCoreConnect Inc. completed an acquisition involving Preferred Dental Development, LLC for $1,200,000 in cash and $400,000 worth of shares of Company common stock at $10.00 per share (closed 2023-10-05).

“On October 5, 2023, the Company and Seller entered into an amendment to the Agreement pursuant to which the parties agreed that in satisfaction of the payment of the cash consideration set forth above, the Company would deliver to the Seller a promissory note and the amount of $1.2 million bearing an interest rate of 12% per annum payable on October 31, 2023.”

Harmony Biosciences Holdings, Inc. completed an acquisition involving Zynerba Pharmaceuticals, Inc. for $1.1059 per Share in cash plus one contingent value right per Share (closed 2023-10-10).

“commenced a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of Zynerba , par value $0.001 per share (the “Shares”), at a price of (i) $ 1.1059 per Share (the “Closing Amount”), in cash, subject to any applicable withholding of taxes and without interest, plus (ii) one contingent value right (each, a “CVR”) per Share ,”

Zynerba Pharmaceuticals, Inc. underwent a change of control involving Harmony Biosciences Holdings, Inc. for $1.1059 per Share plus one contingent value right (closed 2023-10-10).

“commenced a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of the Company, par value $0.001 per share (the “Shares”), at a price of (i) $ 1.1059 per Share (the “Closing Amount”), in cash, subject to any applicable withholding of taxes and without interest, plus (ii) one contingent value right (each, a “CVR”) per Share ,”

Climb Global Solutions, Inc. completed an acquisition involving Michael O’Hara, Francis O’Haire, Roberta McCrossan, David Keating, Alan Smyth and Brian Davis for €15,447,136 plus earn-out (closed 2023-10-06).

“Pursuant to the SPA, on October 6, 2023, Buyer, among other things, purchased the entire share capital of Data Solutions Holdings Limited, a private limited company under the laws of Ireland, (the “Data Solutions Acquisition”) from Seller for an aggregate purchase price of €15,447,136 (subject to certain working capital and other adjustments) plus a potential post-closing earn-out.”

Kaleyra, Inc. underwent a change of control involving Tata Communications Limited for $7.25 (closed 2023-10-05).

“☐ Introductory Note On October 5, 2023, Kaleyra, Inc., a Delaware corporation (the “ Company ” or “ Kaleyra ”), Tata Communications Limited, a company listed on BSE Limited and National Stock Exchange of India Limited (“ Tata Communications ”) and TC Delaware Technologies Inc., a Delaware corporation and wholly owned subsidiary of Tata Communications (“ Merger Sub ”), completed the transactions contemplated by that certain Agreement and Plan of Merger, dated as of June 28, 2023 (the “ Merger Agreement ”), by and among the Company and Tata Communications.”

AMGEN INC completed an acquisition involving Horizon Therapeutics plc for $116.50 in cash (closed 2023-10-06).

“of 11:59 p.m. New York City time on October 5, 2023, the business day prior to the occurrence of the Effective Time (the “ Scheme Record Time ”), obtained the right to receive $116.50 in cash in exchange for each Horizon Share (the “ Consideration ”). In respect of the Horizon Shares issued and outstanding as of the Scheme Record Time, Amgen paid an aggregate”

Horizon Therapeutics Public Ltd Co completed an acquisition involving Amgen Inc. for Acquirer Sub acquired the entire issued ordinary share capital of Horizon (closed 2023-10-06).

“On October 6, 2023 (the “ Closing Date ”), Horizon Therapeutics plc, a public limited company incorporated under the laws of Ireland (“ Horizon ” or the “ Company ”), Amgen Inc., a Delaware corporation (“ Amgen ”) and Pillartree Limited, a private limited company incorporated under the laws of Ireland and a wholly owned subsidiary of Amgen (“ Acquirer Sub ”), completed the transactions contemplated by that certain Transaction Agreement (the “ Transaction Agreement ”), dated as of December 11, 2022, by and among Amgen, Horizon and Acquirer Sub.”

Dolphin Entertainment, Inc. completed an acquisition involving Special Projects Media LLC for $5,000,000 in cash and issued 2,500,000 shares of common stock (closed 2023-10-02).

“the “ Sellers ”). Special Projects is a New York-based talent booking and creative content agency. On the Closing Date, the Company paid the Sellers an aggregate of $5,000,000 in cash and issued 2,500,000 shares of common stock of the Company, par value $0.015 (the “ Common Stock ”) to the Sellers, as consideration for the acquisition of Special”

Global Asset Management Group, Inc. completed an acquisition involving Regenecell, Inc. (closed 2023-09-30).

“On September 30, 2023, the Company completed a Share Exchange in which it acquired a 60% controlling equity interest in Regenecell, Inc., a Florida corporation which has been newly-formed and is engaged in the business of medical travel consulting and referral services.”

CDT Equity Inc. underwent a change of control involving Conduit Pharmaceuticals Limited (Old Conduit) (closed 2023-09-22).

“On September 22, 2023 (the "Closing Date"), the parties completed the Business Combination.”

Envoy Medical, Inc. underwent a change of control involving Envoy Medical Corporation for Each share of Envoy Common Stock converted into the right to receive a number of shares of New Envoy Common Stock equal to the Exchange Ratio of 0.063603; Spons (closed 2023-09-29).

“share of Envoy Common Stock was converted into the right to receive pursuant to the applicable provisions of the Business Combination Agreement. The Exchange Ratio was equal to 0.063603. In addition, pursuant to the subscription agreement, dated April 17, 2023 (as amended to date, the “ Subscription Agreement ”), by and between Anzu and Anzu SPAC GP I LLC (the “”

Estrella Immunopharma, Inc. underwent a change of control involving TradeUP Acquisition Corp. for $325,000,000 (closed 2023-09-29).

“from UPTD, in the aggregate, a number of newly issued shares of common stock of New Estrella (as defined below), par value $0.0001 per share (“Common Stock”) equal to: (i) $325,000,000 (the “Merger Consideration”), divided by (ii) $10.00 per share (such shares of Common Stock is referred as “Merger Consideration Shares”) in consideration of converting their”

AppHarvest, Inc. completed a disposition involving CEFF II AppHarvest Holdings, LLC for credit bid in the amount of $113,179,726 (closed 2023-09-29).

“assets related to the Richmond Business and Morehead Business (each as defined in the Stalking Horse APA, and collectively, the “ Assets ”) for a credit bid in the amount of $113,179,726. On September 19, 2023, the United States Bankruptcy Court for the Southern District of Texas approved the sale. On September 29, 2023, the Sellers and Equilibrium consummated”

Motorsport Games Inc. completed a disposition involving iRacing.com Motorsport Simulations, LLC for $5,000,000 at closing (closed 2023-10-03).

“iRacing paid to 704 $5,000,000 at closing of the transactions contemplated by the Assignment”

KONA GOLD BEVERAGE, INC. completed a disposition involving Sprecher Brewing Company for $450,000 (closed 2023-09-29).

“of that company’s growth strategy that has been in place since 2020. It will be creating a new All Natural Beverage Category with the acquisition of Ooh La Lemin. We received $450,000 at the closing of the transaction, all of which was allocated to the repayment of certain of our debt obligations. The sale included our intellectual property rights to the brand,”

Antiaging Quantum Living Inc. underwent a change of control involving New Lite Ventures LLC (A.K.A. New Living Ventures LLC) (closed 2023-04-10).

“On March 21, 2023, Barry Wan entered into a stock purchase agreement acquiring control of 29,215,000 restricted shares of common stock (the “Purchased Shares”) of Achison Inc. (A.K.A. “Antiaging Quantum Living, Inc.”, the “Company”, “us”, “we” or “our”), representing approximately 97.4% of the Company’s total issued and outstanding common stock (the “Common Stock”) from Dazhong 368 Inc and Sophia 33 Inc, two New York corporations controlled by the Company’s then President, Chief Executive Officer and sole director, Dingshan Zhang pursuant to the terms of a Stock Purchase Agreement by and among the parties thereto (the “Stock Purchase Agreement”). On April 10, 2023, during the closing, Barry Wan assigned all his shares to New Lite Ventures LLC (A.K.A. “New Living Ventures LLC”, “LLC”), a Delaware Limited Liability Company, with which Barry Wan is the sole member. The foregoing transaction resulted in a change of control of the Company, with the LLC acquiring 97.4% of the Company’s outst”

PANACEA LIFE SCIENCES HOLDINGS, INC. completed an acquisition involving Lizard Juice, LLC, Gary Wilder, New Age Distribution, LLC, and N7 Enterprises, Inc. for 78,530 shares of a newly authorized class of convertible preferred stock of the Company (the "Series N-7 Preferred") (closed 2023-09-30).

“on September 30, 2023, the Company completed its acquisition of certain assets related to the Nitro Kava Business from the Sellers in exchange for the issuance of 78,530 shares of N-7 Preferred.”

Atlantic Coastal Acquisition Corp. completed an acquisition involving Porche Capital LTD for total purchase price of $1.00 (closed 2023-10-02).

“of 1934 Date of Report (Date of earliest event reported): September 29, 2023 ATLANTIC COASTAL ACQUISITION CORP. (Exact name of registrant as specified in its charter) Delaware 001-40158 85-4178663 (State or other jurisdiction of incorporation or organization) (Commission File Number) (I.R.S. Employer Identification Number) 1 Woodbury Mews , Dun Laoghaire”

Immunome Inc. underwent a change of control involving Morphimmune Inc. (closed 2023-10-02).

“On October 2, 2023, Immunome, Merger Sub and Morphimmune consummated the transactions contemplated by the Merger Agreement following a special meeting of Immunome’s stockholders on September 29, 2023 (the “Special Meeting”).”

Atlas Energy Solutions Inc. underwent a change of control involving New Atlas HoldCo Inc. (now Atlas Energy Solutions Inc.) (closed 2023-10-02).

“On October 2, 2023, AESI Holdings Inc. (f/k/a Atlas Energy Solutions Inc.), a Delaware corporation (the “ Company ” or “ Old Atlas ”) completed the previously announced Reorganization”

SANFILIPPO JOHN B & SON INC completed an acquisition involving TreeHouse Foods, Inc., Bay Valley Foods, LLC and TreeHouse Private Brands, Inc. for approximately $61 million in cash (closed 2023-09-29).

“On September 29, 2023, the Company closed on the acquisition of the Snack Bar Business for a total of approximately $61 million in cash, subject to certain adjustments.”

CARLISLE COMPANIES INC completed a disposition involving LSF12 Donnelly Bidco, LLC, a Delaware limited liability company and an affiliate of Lone Star Funds for cash consideration in the amount of $520 million, subject to certain customary purchase price adjustments (closed 2023-10-02).

“On October 2, 2023, Carlisle Companies Incorporated, a Delaware corporation (the “Company”), and certain direct and indirect wholly-owned subsidiaries of the Company (each of the Company and such direct and indirect wholly-owned subsidiaries of the Company, a “Seller” and, collectively, the “Sellers”), and LSF12 Donnelly Bidco, LLC, a Delaware limited liability company and an affiliate of Lone Star Funds (“Buyer”), completed the transaction contemplated by the Equity Purchase Agreement, dated as of June 14, 2023 (the “Agreement”). Pursuant to the Agreement, the Sellers sold to Buyer equity interests comprising the Company’s Carlisle Fluid Technologies business segment (the “Acquired Business”) in exchange for cash consideration in the amount of $520 million, subject to certain customary purchase price adjustments.”

KELLANOVA completed a disposition involving WK Kellogg Co (closed 2023-09-29).

“On the Distribution Date, Kellanova completed the previously announced Spin-Off of WK Kellogg”